533
Views
24
CrossRef citations to date
0
Altmetric
Reviews

Targeting integrins in hepatocellular carcinoma

, , &
Pages 421-437 | Published online: 21 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Malwina Sosnowska, Marta Kutwin, Sławomir Jaworski, Barbara Strojny, Mateusz Wierzbicki, Jarosław Szczepaniak, Maciej Łojkowski, Wojciech Święszkowski, Jaśmina Bałaban, André Chwalibog & Ewa Sawosz. (2019) Mechano-signalling, induced by fullerene C60 nanofilms, arrests the cell cycle in the G2/M phase and decreases proliferation of liver cancer cells. International Journal of Nanomedicine 14, pages 6197-6215.
Read now
David Fuentes, Nina M. Muñoz, Chunxiao Guo, Urzsula Polak, Adeeb A. Minhaj, William J. Allen, Michael C. Gustin & Erik N. K. Cressman. (2018) A molecular dynamics approach towards evaluating osmotic and thermal stress in the extracellular environment. International Journal of Hyperthermia 35:1, pages 559-567.
Read now
Monira Hoque, Carles Rentero, James R Conway, Rachael Z Murray, Paul Timpson, Carlos Enrich & Thomas Grewal. (2015) The cross-talk of LDL-cholesterol with cell motility: Insights from the Niemann Pick Type C1 mutation and altered integrin trafficking. Cell Adhesion & Migration 9:5, pages 384-391.
Read now

Articles from other publishers (21)

Po-Da Chen, Ying-Yu Liao, Yu-Chia Cheng, Hsin-Yi Wu, Yao-Ming Wu & Min-Chuan Huang. (2023) Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway. Oncogenesis 12:1.
Crossref
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen & Adriaan G. Holleboom. (2023) Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers 15:4, pages 1308.
Crossref
Jian-Rui Chen, Jing-Tong Zhao & Zhen-Zhen Xie. (2022) Integrin-mediated cancer progression as a specific target in clinical therapy. Biomedicine & Pharmacotherapy 155, pages 113745.
Crossref
Gerda Schicht, Lena Seidemann, Rene Haensel, Daniel Seehofer & Georg Damm. (2022) Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma. Cancers 14:17, pages 4227.
Crossref
Mazen A. Juratli, He Zhou, Elsie Oppermann, Wolf O. Bechstein, Andreas Pascher, Felix K.-H. Chun, Eva Juengel, Jochen Rutz & Roman A. Blaheta. (2022) Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells. Cancers 14:10, pages 2430.
Crossref
Devaraj Ezhilarasan. (2021) Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. Journal of Cellular Physiology 237:1, pages 436-449.
Crossref
Xin Li, Pierluigi Ramadori, Dominik Pfister, Marco Seehawer, Lars Zender & Mathias Heikenwalder. (2021) The immunological and metabolic landscape in primary and metastatic liver cancer. Nature Reviews Cancer 21:9, pages 541-557.
Crossref
Gang Ning, Yongqiang Li, Wenji Chen, Wenjuan Tang, Diwen Shou, Qingling Luo, Huiting Chen & Yongjian Zhou. (2021) Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients. Journal of Oncology 2021, pages 1-18.
Crossref
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris & Tanuja Singh. (2021) Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets 22:7, pages 779-792.
Crossref
Chunyan Zhang, Huan Yang, Liwei Pan, Guangfu Zhao, Ruofei Zhang, Tianci Zhang, Zhixiong Xiao, Ying Tong, Yi Zhang, Richard Hu, Stephen Pandol & Yuan-Ping Han. (2021) Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells. Cancers 13:5, pages 1181.
Crossref
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro & Giovanni Musso. (2019) Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 20:7, pages 1745.
Crossref
Meng-Yu Wu, Giuo-Teng Yiang, Pei-Wen Cheng, Pei-Yi Chu & Chia-Jung Li. (2018) Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. Journal of Clinical Medicine 7:8, pages 213.
Crossref
Meng Lu, Jiao Wu, Zhi‐Wei Hao, Yu‐Kui Shang, Jing Xu, Gang Nan, Xia Li, Zhi‐Nan Chen & Huijie Bian. (2018) Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology 68:1, pages 317-332.
Crossref
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo & Olorunseun O. Ogunwobi. 2018. Precision Molecular Pathology of Liver Cancer. Precision Molecular Pathology of Liver Cancer 131 152 .
Yuya Miyauchi, Kentaro Yasuchika, Ken Fukumitsu, Takamichi Ishii, Satoshi Ogiso, Takahito Minami, Hidenobu Kojima, Ryoya Yamaoka, Hokahiro Katayama, Takayuki Kawai, Elena Yukie Yoshitoshi-Uebayashi, Sadahiko Kita, Katsutaro Yasuda, Naoya Sasaki & Shinji Uemoto. (2017) A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells. Scientific Reports 7:1.
Crossref
Jing-Jun Yan, Jia-Zhi Liao, Ju-Sheng Lin & Xing-Xing He. (2014) Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems. Tumor Biology 36:1, pages 55-67.
Crossref
Michael C. Wallace & Scott L. Friedman. (2014) Hepatic Fibrosis and the Microenvironment: Fertile Soil for Hepatocellular Carcinoma Development. Gene Expression 16:2, pages 77-84.
Crossref
Martin Y.M. Chiang, Yanzi Yangben, Nancy J. Lin, Julia L. Zhong & Li Yang. (2013) Relationships among cell morphology, intrinsic cell stiffness and cell–substrate interactions. Biomaterials 34:38, pages 9754-9762.
Crossref
Cyrill Géraud, Carolin Mogler, Anja Runge, Konstantin Evdokimov, Shun Lu, Kai Schledzewski, Bernd Arnold, Günter Hämmerling, Philipp S. Koch, Kai Breuhahn, Thomas Longerich, Alexander Marx, Christel Weiss, Friederike Damm, Astrid Schmieder, Peter Schirmacher, Hellmut G. Augustin & Sergij Goerdt. (2013) Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival. Liver International 33:9, pages 1428-1440.
Crossref
Dan Ding, Kai Li, Wei Qin, Ruoyu Zhan, Yong Hu, Jianzhao Liu, Ben Zhong Tang & Bin Liu. (2013) Conjugated Polymer Amplified Far-Red/Near-Infrared Fluorescence from Nanoparticles with Aggregation-Induced Emission Characteristics for Targeted In Vivo Imaging. Advanced Healthcare Materials 2:3, pages 500-507.
Crossref
Xiao-Lin Zhang, Hao Yu, You-Yi Xiong, Shi-Tang Ma, Lei Zhao & Shi-Feng She. (2013) Resveratrol Down-Regulates Myosin Light Chain Kinase, Induces Apoptosis and Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Rats. International Journal of Molecular Sciences 14:1, pages 1940-1951.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.